再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REGN 再生元制药公司

已收盘 07-15 16:00:00 EDT

547.96

-22.63

-3.97%

盘后547.96

+0.000.00%

19:59 EDT

最高574.75	最低546.28	成交量99.86万
今开574.15	昨收570.59	日振幅4.99%
总市值591.61亿	流通市值547.36亿	总股本1.08亿
成交额5.52亿	换手率1.00%	流通股本9,989万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"再生元制药公司","latestPrice":547.96,"timestamp":1752609600000,"preClose":570.59,"halted":0,"volume":998623,"hourTrading":{"tag":"盘后","latestPrice":547.96,"preClose":547.96,"latestTime":"19:59 EDT","volume":21683,"amount":11881414.9844,"timestamp":1752623974350},"delay":0,"floatShares":99889916,"shares":107965497,"eps":39.427654,"marketStatus":"已收盘","change":-22.63,"latestTime":"07-15 16:00:00 EDT","open":574.15,"high":574.75,"low":546.28,"amount":552344772.4872,"amplitude":0.049896,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":39.427654,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752652800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":570.59,"dividendRate":0.003212,"preHourTrading":{"tag":"盘前","latestPrice":571.21,"preClose":570.59,"latestTime":"09:29 EDT","volume":201,"amount":114593.35620000001,"timestamp":1752586144271},"postHourTrading":{"tag":"盘后","latestPrice":547.96,"preClose":547.96,"latestTime":"19:59 EDT","volume":21683,"amount":11881414.9844,"timestamp":1752623974350},"volumeRatio":1.223586,"impliedVol":0.4222,"impliedVolPercentile":0.752},"requestUrl":"/m/hq/s/REGN/tweets","defaultTab":"tweets","newsList":[{"id":"1140863699","title":"纳斯达克100指数表现：2025年7月15日EDT下午2:45最佳与最差股票盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=1140863699","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140863699?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:47","pubTimestamp":1752605232,"startTime":"0","endTime":"0","summary":"2025年7月15日美国东部时间下午约2:45，纳斯达克100指数呈现明显波动格局。该指数上涨119.34点，涨幅0.53%，收于22,974.97点。在成分股中，上涨股票仅34只，而下跌股票多达67只，下跌股数量远超上涨股约两倍。此外，六只股票创下新高，一只股票录得新低。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0056508442.USD","LU0347712357.USD","LU1880398554.USD","IE00BWXC8680.SGD","LU1935043536.SGD","LU2065169927.USD","LU0823434583.USD","LU1951198990.SGD","LU2211815571.USD","LU1429558221.USD","LU2505996509.AUD","LU2750360641.GBP","LU2461242641.AUD","LU0882574055.USD","LU0203201768.USD","LU1861220033.SGD","BK4527","LU0109392836.USD","LU0097036916.USD","LU0342679015.USD","IE00B775H168.HKD","LU0345768740.USD","LU0477156953.USD","LU1721428933.USD","LU0070302665.USD","LU1323610961.USD","SNPS","SG9999015978.USD","SGXZ81514606.USD","LU0648000940.SGD","LU0823421416.USD","SG9999014575.USD","LU2362541273.HKD","LU1674673428.USD","LU2357125470.USD","BK4550","BK4568","LU0823434740.USD","NVD3.UK","IE00BMPRXQ63.HKD","LU2089984988.USD","BK4578","BK4598","LU0683600562.USD","LU0980610538.SGD","LU0861579265.USD","LU0053666078.USD","SG9999002224.SGD","LU0820562030.AUD","LU0868494617.USD","NVDD","LU2106854487.HKD","LU1868836757.USD","LU2452424414.USD","IE00BYXW3230.USD","LU1244550577.SGD","IE00BMPRXR70.SGD","LU0528227936.USD","SG9999004303.SGD","LU2168564495.EUR","LU1815336760.USD","LU1868837136.USD","LU2092937148.SGD","SG9999000418.SGD","LU2247934214.USD","LU1585245621.USD","IE00BK4W5M84.HKD","BK4588","LU1989764748.USD","LU0511384066.AUD","LU2237957811.SGD","LU0096364046.USD","SG9999015952.SGD","BIIB","LU2242650005.HKD","LU2286300806.USD","LU1778281490.HKD","LU2360107168.USD","LU0094547139.USD","LU2506951792.HKD","IE00B3T34201.USD","LU2250418816.HKD","LU1244550221.USD","LU0345770308.USD","LU0957808578.USD","NVDL","BK4587","IE00BK4W5L77.USD","LU1366333091.USD","LU1066051498.USD","LU1934455277.USD","LU2244417387.USD","LU0238689110.USD","LU1242518931.SGD","LU1267930573.SGD","LU2098885051.SGD","LU0353189763.USD","SNVD.UK","BK4554","LU0942090050.USD","IE00BJTD4V19.USD","LU2381873111.SGD","LU2125909593.SGD","BK4551","LU2543165471.USD","LU0787776722.HKD","LU1923622291.USD","BK4609","IE00BFSS7M15.SGD","LU0472753341.HKD","IE00B3M56506.USD","LU0203202063.USD","LU0127658192.USD","LU2265009873.SGD","SG9999014559.SGD","LU2294711713.HKD","IE00BN29S564.USD","LU0444973449.USD","LU1974910355.USD","LU0310800379.SGD","LU0494093205.USD","LU1232071149.USD","LU2361044949.HKD","LU0077335932.USD","LU2403377893.USD","LU1116320901.HKD","LU0979878070.USD","LU2324357040.USD","LU0353189680.USD","LU2290526834.HKD","LU0124676726.USD","LU2125154778.USD","IE00BD6J9T35.USD","LU2458330169.SGD","SGXZ51526630.SGD","IE00BJJMRX11.SGD","LU2063271972.USD","LU0348723411.USD","LU1868837300.USD","IE00BQXX3F31.USD","SG9999002232.USD","LU2083900584.USD","LU0170899867.USD","BK4503","LU0079474960.USD","LU0289960550.SGD","IE00BZ1G4Q59.USD","LU2023250504.SGD","LU2125909247.SGD","LU2456880835.USD","IE00B1BXHZ80.USD","IE00BDCRKT87.USD","LU1988902786.USD","IE00BFSS8Q28.SGD","LU2491050154.USD","ARM","LU1718418525.SGD","LU2468319806.SGD","LU1035775433.USD","IE00BJJMRY28.SGD","LU2471134523.USD","NVDS","LU2108987350.USD","NVDX","LU1699723380.USD","LU2237957902.USD","IE00B19Z8X17.USD","LU0444971666.USD","LU0820561909.HKD","LU0130517989.USD","LU0672654240.SGD","IE00B19Z9Z06.USD","LU2430703095.HKD","LU1571399168.USD","LU2236285917.USD","LU2237438978.USD","LU1037948541.HKD","BK4528","IE0034235188.USD","LU0724617625.USD","LU0965509101.SGD","LU2471134952.CNY","NVDY","LU0820561818.USD","LU2097344357.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU1935042215.USD","TTD","LU0107464264.USD","LU0187121727.USD","LU0265550359.USD","LU2462157665.USD","IE00B894F039.SGD","LU2326559502.SGD","LU0323591593.USD","SG9999015986.USD","LU0081259029.USD","LU1064131342.USD","GB00BDT5M118.USD","LU1923623000.USD","LU2092627202.USD","LU0289739343.SGD","LU1316542783.SGD","LU2471134796.USD","LU0345769128.USD","LU0080751232.USD","LU1066053197.SGD","LU1868836591.USD","LU2756315664.SGD","LU0211331839.USD","LU2463028550.USD","BK4567","LU0157215616.USD","LU0274383776.USD","IE00BZ199S13.USD","LU0689626769.HKD","LU0058720904.USD","CPRT","LU2417539215.USD","LU0061474705.USD","LU2191332357.HKD","LU1496350502.SGD","BK4534","LU1839511570.USD","LU0198837287.USD","BK4543","BK4579","LU1430594728.SGD","LU2552382215.SGD","IE0004091025.USD","IE00BHPRN162.USD","LU0417517546.SGD","LU0642271901.SGD","IE0009356076.USD","LU0323240290.USD","LU0289739699.SGD","LU2491050071.SGD","IE0034235303.USD","LU0889565833.HKD","LU0390134368.USD","LU0786609619.USD","LU0965508806.USD","BK4612","LU0130103400.USD","LU0708995401.HKD","LU2413666426.HKD","LU1814569148.SGD","LU1674673691.USD","HK0000320223.HKD","LU0276348264.USD","IE00BQXX3C00.GBP","AMD","LU1261432733.SGD","LU1435385759.SGD","LU2087621335.USD","LU0256863902.USD","LU1629891620.HKD","LU2552382058.USD","LU0154236417.USD","LU2592432038.USD","IE00B19Z3B42.SGD","BK4592","LU1934455863.HKD","LU0965509283.SGD","LU2125909759.SGD","IE00BMPRXN33.USD","BK4585","IE00BQXX3D17.EUR","LU0048584097.USD","BK4532","LU0788109477.HKD","LU2298321311.HKD","LU0267386448.USD","LU1280957306.USD","LU0345769631.USD","LU1303367103.USD","LU2746668461.USD","IE00BJLML261.HKD","LU1366192091.USD","BK4533","LU2433249047.HKD","LU1066051225.USD","LU2357305700.SGD","IE0004086264.USD","SG9999014542.SGD","LU2213496289.HKD","LU0061475181.USD","LU1201861249.SGD","LU1791710400.SGD","LU0130518102.USD","LU1935042488.USD","LU1989772840.SGD","LU1935042991.SGD","LU0889565916.HKD","BK4605","LU0308772762.SGD","LU1623119135.USD","IE00B7SZLL34.SGD","LU0689472784.USD","LU0354030511.USD","BK4141","LU0006306889.USD","BK4575","LU1989772923.USD","LU2023250330.USD","LU2168564222.USD","IE0002270589.USD","LU1804176565.USD","LU0466842654.USD","LU1720051108.HKD","LU0215105999.USD","LU1852331112.SGD","IE0008368304.USD","LU0072462426.USD","LU1548497426.USD","3NVD.UK","LU0823414551.USD","HK0000306685.HKD","LU0557290698.USD","LU2756315318.SGD","IE00BKVL7J92.USD","BK4009","LU0225283273.USD","LU1821325948.USD","LU1803068979.SGD","IE00B19Z8W00.USD","IE00B7KXQ091.USD","LU0477156797.USD","LU1244550494.USD","BK4614","LU1145028129.USD","LU2505996681.GBP","LU2750360997.AUD","LU0868494708.USD","HK0000306701.USD","BK4608","IE0004445015.USD","LU2087625088.SGD","LU0943347566.SGD","IE00B1XK9C88.USD","LU2552382132.HKD","LU1116320737.USD","LU1712237335.SGD","LU1633808545.USD","LU2168564065.EUR","LU2361045086.USD","BK4581","SG9999014567.USD","LU1066051811.HKD","LU0208291251.USD","LU2054465674.USD","LU2360032135.SGD","LU0061474960.USD","LU0057025933.USD","IE0005OL40V9.USD","LU1201861165.SGD","LU2471134879.HKD","LU1861215975.USD","LU1791710582.SGD","BK4529","LU0106261372.USD","LU1914381329.SGD","IE00BKDWB100.SGD","LU0109394709.USD","LU1119994496.HKD","LU0029864427.USD","LU1069344957.HKD","LU0985320562.USD","LU0069063385.USD","LU1720051017.SGD","SG9999015341.SGD","LU1951200564.SGD","LU0708994859.HKD","BK4613","IE00BJTD4N35.SGD","LU2089985449.USD","NVDU","BK4023","LU1815333072.USD","LU0320765992.SGD","LU0719512351.SGD","BK4100","LU2602419157.SGD","IE0004445239.USD","LU2249611893.SGD","LU2077746001.SGD","GILD","LU1934455194.USD","LU1242518857.USD","NVDA","LU0251132253.USD","IE00B5949003.HKD","LU0316494557.USD","LU0957791311.USD","LU0114720955.EUR","BK4566","LU0823421333.USD","SGXZ99366536.SGD","LU0965509010.AUD","IE00B4JS1V06.HKD","2NVD.UK","LU0320765059.SGD","BK4137","LU0640476718.USD","LU2125154935.USD","IE00BDRTCR15.USD","LU2491049909.HKD","SG9999001424.SGD","LU2413666699.HKD","NVDS.UK","LU1861127337.USD","LU0130102774.USD","IE0034235295.USD","NVIW.SI","LU2420271590.USD","NVD","LU2041044095.USD","LU2360106780.USD","LU1983260115.SGD","LU2362540622.SGD","LU0823414478.USD","LU1642822529.SGD","LU2168564149.EUR","LU1127390331.HKD","LU0476273544.USD","LU1880398471.USD","LU2125909916.SGD","LU0128525929.USD","LU1551013342.USD","BK4139","LU1037948897.HKD","LU2242649171.HKD","BK4559","CHTR","LU0234572021.USD","LU0265550946.USD","LU2168563687.JPY","REGN","LU2430703251.USD","LU0354030438.USD","LU2092937221.SGD","BK4549","BK4548","IE00B19Z9505.USD","LU0096362180.USD","BK4573","LU0320765489.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU0345768153.USD","LU2065170008.USD","LU2458330243.SGD","LU1084165304.USD","LU2430703178.SGD","IE00BKPKM429.USD","LU0323239441.USD","LU2361044865.SGD","HK0000320264.USD","IE00BSNM7G36.USD","BK4583","LU1935043023.USD","LU0175139822.USD","LU1496350171.SGD","LU2264538146.SGD","LU2065171402.SGD","LU1923622614.USD","LU0234570918.USD","SG9999015945.SGD","LU2065171311.SGD","LU0109391861.USD","LU0256863811.USD","LU1868836914.USD","LU0082616367.USD","LU0648001328.SGD","LU0266013472.USD","LU0289961442.SGD","LU2360108059.USD","LU0345770993.USD","SG9999015358.SGD","SGXZ23171101.USD","LU2097344431.USD","LU1989764664.SGD","BK4512","LU1267930730.SGD","LU0882574139.USD","NVD2.UK","LU0964807845.USD","LU1551013425.SGD","LU1917777945.USD"],"gpt_icon":1},{"id":"1150814878","title":"中国生物科技企业突围！恒瑞减肥新药HRS9531临床数据直逼礼来Zepbound","url":"https://stock-news.laohu8.com/highlight/detail?id=1150814878","media":"华尔街洞察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150814878?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:19","pubTimestamp":1752603565,"startTime":"0","endTime":"0","summary":"周二公布的临床试验结果显示，中国药企恒瑞医药开发的减肥注射剂HRS9531疗效直逼礼来公司的重磅产品Zepbound，这再次印证了中国生物科技产业对美国医药巨头的潜在冲击力。恒瑞医药与其美国合作伙伴Kailera Therapeutics披露的三期临床试验数据显示，接受HRS9531治疗的受试者在48周内平均减重达18%。更关键的是，此次试验并未采用HRS9531的最高剂量方案。恒瑞医药计划基于最新数据在中国\"尽快\"提交上市申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","LU1057294990.SGD","LU2264538146.SGD","LU2362540622.SGD","LU0234572021.USD","REGN","LU0320765992.SGD","LU2471134796.USD","LU1989771016.USD","LU2211815571.USD","SGXZ31699556.SGD","LU1720051108.HKD","BK4568","SG9999015986.USD","LU1366192091.USD","SGXZ99366536.SGD","LU0097036916.USD","BK4139","LU2491049909.HKD","LU1280957306.USD","SG9999014914.USD","SG9999014906.USD","LU2324357040.USD","LU0154236417.USD","LU1712237335.SGD","BK4533","IE00BZ1G4Q59.USD","LU1868836591.USD","LU2552382058.USD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU1035775433.USD","LU1868837136.USD","LU2360106947.USD","BK4581","LU1917777945.USD","LU1127390331.HKD","LU2237443382.USD","LU2357305700.SGD","IE00BJT1NW94.SGD","LU2471134523.USD","LU2063271972.USD","LU2106854487.HKD","LU2237443895.HKD","SG9999001176.SGD","LU0823434740.USD","LU2362541513.USD","LU2112291526.USD","LU2361045086.USD","LU2237443549.SGD","LU1868836757.USD","LU0471298777.SGD","LU1623119135.USD","LU1093756168.USD","LU1551013342.USD","LU2236285917.USD","LU0203201768.USD","LU2750360997.AUD","SGXZ57979304.SGD","LU1720051017.SGD","LU0256863902.USD","SGXZ51526630.SGD","LU2471134952.CNY","LU0316494557.USD","LU0689472784.USD","SG9999015945.SGD","NVO","IE00BFTCPJ56.SGD","LU0882574055.USD","BK4585","LU1064131342.USD","LU2462157665.USD","LU0417517546.SGD","LU2089984988.USD","IE0002141913.USD","LU0053666078.USD","LU0106261372.USD","LU1291159041.SGD","LU2750360641.GBP","SG9999018857.SGD","LU2417539215.USD","LU0256863811.USD","LU1974910355.USD","LU2361044949.HKD","LU0456855351.SGD","LU0203202063.USD","LU0079474960.USD","LU0114720955.EUR","IE0004445239.USD","LU0889565916.HKD","LU2023250504.SGD","LU2362541273.HKD","SG9999015978.USD","IE00BK4W5L77.USD","BK4599","LU2237438978.USD","SGXZ81514606.USD","LU0823434583.USD","LU1548497426.USD","LU1267930730.SGD","LU0266013472.USD","LU0943347566.SGD","AZN","LU1069344957.HKD","BK4007","LU1814569148.SGD","LU0354030511.USD","LU0323591593.USD","LU0320765059.SGD","LU2456880835.USD","LU0786609619.USD","SG9999014898.SGD","LU2237443622.USD","SG9999015952.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJLML261.HKD","LU0006306889.USD","LU0882574139.USD","LU0109394709.USD","IE00BK4W5M84.HKD","LU0354030438.USD","BK4534","LU0471298694.HKD","LU0672654240.SGD","LU2491050071.SGD","LU1023059063.AUD","SG9999013999.USD","LU1829250122.USD","LU1551013425.SGD","LU2237443978.SGD","LU1988902786.USD","LU1868837300.USD","LU0096364046.USD","LU0820561909.HKD","LU2602419157.SGD","LU2746668461.USD","LU1804176565.USD","LU2265009873.SGD","LU0198837287.USD","LU2237443465.HKD","LU2461242641.AUD","IE0009355771.USD","LU0708995401.HKD","LU0094547139.USD","SG9999014880.SGD","LU0122379950.USD","LU0289739699.SGD","LU2361044865.SGD","LU0385154629.USD","BK4588","SG9999017495.SGD","IE00BKVL7J92.USD","LU0238689110.USD","LU0061475181.USD","LU2552382215.SGD","LU1232071149.USD","LU0820561818.USD","SG9999001176.USD","BK4532","LU0058720904.USD","LU0640476718.USD","LLY","LU2468319806.SGD","LU1061106388.HKD","LU1983299246.USD","LU1093756325.SGD","BK4516","GB00BDT5M118.USD","IE00BJJMRZ35.SGD","LU2471134879.HKD","SG9999018865.SGD","LU1868836914.USD","LU0466842654.USD","LU2491050154.USD","LU0823416689.USD"],"gpt_icon":1},{"id":"2551019152","title":"Lilly's Zepbound Faces a Potential Weight-Loss Rival. It's Made by a Chinese Biotech. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2551019152","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551019152?lang=zh_cn&edition=full","pubTime":"2025-07-16 01:50","pubTimestamp":1752601800,"startTime":"0","endTime":"0","summary":"A Chinese-developed weight loss shot looked almost as good as Eli Lilly's megablockbuster Zepbound in late-stage trial results rolled out Tuesday morning, in one more sign of the impending disruption that the booming Chinese biotech industry could bring to U.S. biopharma.The Jiangsu, China-based company Hengrui Pharma and its privately held U.S. partner Kailera Therapeutics said early Tuesday that patients lost an average of 18% of their weight over 48 weeks on Hengrui's drug, HRS9531.Using a statistical measure that only takes into account patients who completed the trial, their average weight loss was 19%.That's still not quite as good as Zepbound, which led to 21% weight loss in a late-stage trial. But the Zepbound trial was longer, and Hengrui and Kailera say that patients were still losing weight when the Hengrui trial ended. What's more, the latest Hengrui trial didn't study HRS9531 at its highest dose level.It all adds complexity for investors trying to forecast the shape of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"礼来公司的Zepbound面临着潜在的减肥竞争对手。它是由一家中国生物技术公司制造的。——Barrons.com","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","LU2552382058.USD","LU0109391861.USD","LU0154236417.USD","BK4139","LU2265009873.SGD","SG9999013999.USD","IE00BZ1G4Q59.USD","LU2471134796.USD","REGN","LU2456880835.USD","LU1057294990.SGD","SGXZ31699556.SGD","LU1988902786.USD","LU1868836591.USD","BK4007","LLY","LU2461242641.AUD","LU2471134952.CNY","LU0114720955.EUR","SG9999014898.SGD","SG9999018857.SGD","LU2361044949.HKD","LU0820561818.USD","LU2362541513.USD","LU0097036916.USD","BK4599","AZN","LU1267930730.SGD","LU2468319806.SGD","BK4585","LU0640476718.USD","SG9999017495.SGD","SG9999018865.SGD","LU2106854487.HKD","LU2361044865.SGD","LU1868836757.USD","SG9999014880.SGD","LU0943347566.SGD","LU0323591593.USD","SG9999014914.USD","LU2552382132.HKD","LU1061106388.HKD","LU2746668461.USD","LU1712237335.SGD","BK4534","LU0672654240.SGD","LU2361045086.USD","SG9999015945.SGD"],"gpt_icon":1},{"id":"1146375149","title":"纳指100成分股盘中表现分化：贸易平台飙涨8.6%，DoorDash领跌近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146375149","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146375149?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:03","pubTimestamp":1752591789,"startTime":"0","endTime":"0","summary":"北京时间7月15日23:01，纳斯达克100指数成分股呈现明显分化格局。涨幅方面，贸易平台以8.6%的涨幅领跑，超威半导体紧随其后上涨6.5%，英伟达上扬4.2%，新思科技与拼多多分别录得2.3%及2.0%的涨幅。跌幅榜单中，DoorDash下挫2.9%垫底，再生元制药及吉利德科学双双下跌2.5%，星座能源与特许通讯分别走低2.4%和2.2%。截至当前时段，纳斯达克100指数微涨0.33%，报22,930.92点，累计攀升75.29点。盘中5只成分股创历史新高，1只触及新低。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030438.USD","LU2106854487.HKD","LU0868494708.USD","LU0077335932.USD","LU2242649171.HKD","LU2461242641.AUD","LU0821914370.USD","LU0329678170.USD","LU1988902786.USD","LU0588546209.SGD","LU0080751232.USD","LU0348805143.USD","BK4573","BK4550","LU1868837300.USD","LU2065169927.USD","LU2077746001.SGD","SGXZ23171101.USD","LU2592432038.USD","LU0289739699.SGD","IE00B19Z8X17.USD","IE00BFSS7M15.SGD","LU2125909593.SGD","LU0689626769.HKD","LU1093756168.USD","LU1571399168.USD","LU2456880835.USD","LU0316494557.USD","LU0359201885.HKD","LU0069063385.USD","LU1496350171.SGD","BK4558","LU1316542783.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","SG9999002463.SGD","IE00B19Z3B42.SGD","LU0980610538.SGD","IE00BJTD4V19.USD","LU0985320562.USD","LU1778281490.HKD","IE00B5949003.HKD","IE00BD6J9T35.USD","LU2244417387.USD","LU2054465674.USD","IE00B775H168.HKD","LU1880398471.USD","LU1435385759.SGD","LU0965509010.AUD","BK4579","NVDA","LU1145028129.USD","IE00BJJMRY28.SGD","LU0265550946.USD","LU2265009873.SGD","LU0472753341.HKD","LU1244550221.USD","LU1280957306.USD","LU0786609619.USD","IE00BD4GTV84.USD","LU0719512351.SGD","LU2430703178.SGD","LU2362540622.SGD","LU1037948897.HKD","BK4023","IE00B1BXHZ80.USD","LU1048596156.SGD","LU0823397285.USD","LU1303224171.USD","LU1720051108.HKD","BK4536","LU0557290698.USD","IE00B19Z3581.USD","LU0516422366.SGD","LU0823414551.USD","IE00BFSS8Q28.SGD","IE00BK4W5L77.USD","LU0096362180.USD","LU0072462343.USD","LU0477156953.USD","LU0359202008.SGD","LU0965509283.SGD","LU1923622614.USD","LU0198837287.USD","HK0000306701.USD","LU1769817096.USD","IE00B1XK9C88.USD","LU2213496289.HKD","LU1720051017.SGD","BK4598","LU1066053197.SGD","LU1720050803.USD","LU0823421333.USD","IE0005OL40V9.USD","LU0589944569.HKD","BK4588","LU0345768153.USD","LU2361044949.HKD","NVD3.UK","LU2552382215.SGD","LU0051755006.USD","BK4605","LU2552382058.USD","IE00BN29S564.USD","BK4568","LU0345769631.USD","LU0820562030.AUD","LU1769817179.HKD","IE00B19Z9505.USD","IE0034235303.USD","BK4534","LU2750360641.GBP","NVIW.SI","LU2087589342.USD","NVD","IE00BKPKM429.USD","BK4613","LU2247934214.USD","NVDY","LU0057025933.USD","LU1116320901.HKD","LU1642822529.SGD","GILD","LU1821325948.USD","LU0143863198.USD","SG9999014559.SGD","LU0444971666.USD","LU2097344431.USD","IE00B4JS1V06.HKD","LU0724617625.USD","LU1201861249.SGD","BK4566","SG9999002562.SGD","LU1127390331.HKD","BK4531","LU2360106780.USD","LU1868836591.USD","LU0154236417.USD","IE00BYXW3230.USD","LU0942090050.USD","LU1718418525.SGD","IE0004091025.USD","LU0049112450.USD","LU1880383366.USD","LU0444973449.USD","LU1235295612.USD","BK4554","LU1551013425.SGD","IE00BHPRN162.USD","LU0642271901.SGD","LU0868494617.USD","SG9999014674.SGD","LU0327786744.USD","LU0320764599.SGD","LU2249611893.SGD","LU0820561818.USD","LU1803068979.SGD","IE00B3T34201.USD","LU0823038988.USD","LU1261432733.SGD","LU1430594728.SGD","LU0320765059.SGD","LU1983260115.SGD","LU2491050154.USD","LU1861127337.USD","LU1852331112.SGD","LU0516423091.SGD","LU0708995401.HKD","LU2602419157.SGD","LU0211331839.USD","LU1868836757.USD","LU1323998911.USD","IE00BJJMRX11.SGD","LU2543165471.USD","LU1880398554.USD","LU0345770993.USD","LU2125909759.SGD","LU2505996509.AUD","LU1935043536.SGD","LU1923622291.USD","LU1712237335.SGD","LU1699723380.USD","LU0052750758.USD","LU1989764748.USD","LU0882574055.USD","LU0187121727.USD","LU2471134879.HKD","LU2417539215.USD","BK4081","LU0359201612.USD","BK4503","LU1951200564.SGD","LU2125909247.SGD","LU2236285917.USD","LU1721428933.USD","LU1934455194.USD","LU2413666699.HKD","SG9999002828.SGD","LU1244550494.USD","LU0124676726.USD","IE00BKVL7J92.USD","BK4533","LU0650527681.SGD","SNVD.UK","IE0034235188.USD","IE0034224299.USD","LU1839511570.USD","LU1868837565.USD","LU1923623000.USD","LU0823413587.USD","LU2089984988.USD","LU2357305700.SGD","LU1046422090.SGD","LU1267930573.SGD","LU0347712357.USD","LU0234570918.USD","SG9999014575.USD","BK4535","BK4575","IE00BK4W5M84.HKD","LU1429558221.USD","LU2242650005.HKD","LU2065170008.USD","LU1623119135.USD","LU0130102774.USD","LU1244550577.SGD","LU0417517546.SGD","LU0683595622.HKD","LU2452424414.USD","LU0265550359.USD","SG9999014567.USD","LU0307460666.USD","SNPS","BK4612","LU1935042215.USD","LU2237957811.SGD","LU0143863784.USD","LU1989772923.USD","LU0648001328.SGD","IE00B3M56506.USD","LU1934455277.USD","LU1917777945.USD","LU1267930730.SGD","LU2065171402.SGD","LU0225283273.USD","LU0109391861.USD","LU0737861772.HKD","LU1981816686.USD","LU0029864427.USD","LU1066051225.USD","LU0175139822.USD","LU0328353924.USD","LU2361045086.USD","LU0140636845.USD","LU0107464264.USD","LU1035775433.USD","BK4551","LU2756315318.SGD","BK4122","BK4578","LU2458330243.SGD","LU0633140560.USD","BK4606","LU0683600562.USD","SG9999015945.SGD","LU0823039010.USD","LU0823434740.USD","LU2168564495.EUR","LU0477156797.USD","LU0235996351.USD","LU2242644610.SGD","LU0957791311.USD","LU0203202063.USD","IE00BDRTCR15.USD","LU0672654240.SGD","IE0004086264.USD","LU1791710582.SGD","LU0276348264.USD","BK4100","LU0127658192.USD","LU0048580855.USD","LU0289739343.SGD","LU1934455863.HKD","LU0130517989.USD","LU0094547139.USD","BK4141","LU0528227936.USD","IE0009356076.USD","LU1719994722.HKD","LU0164865239.USD","LU1366333091.USD","LU0274383776.USD","LU2746668461.USD","LU0203201768.USD","LU1935042991.SGD","LU0157215616.USD","LU0594300419.USD","BK4501","NVDS.UK","2NVD.UK","LU0965508806.USD","BK4583","LU0128525929.USD","LU0106261372.USD","LU2191332357.HKD","IE00B19Z8W00.USD","LU2468319806.SGD","LU2750360997.AUD","LU0889565833.HKD","LU0511384066.AUD","LU1251922891.USD","BK4504","LU2168564222.USD","LU2471134952.CNY","IE0002270589.USD","LU0456846285.SGD","LU1674673691.USD","HK0000306685.HKD","LU1868836914.USD","SG9999015978.USD","LU1242518857.USD","LU2381873111.SGD","BK4567","LU2257852520.SGD","CEG","LU0289960550.SGD","BK4553","IE00BZ1G4Q59.USD","LU1048588211.SGD","BK4581","REGN","LU2362541273.HKD","LU2087625088.SGD","LU2063271972.USD","LU0455707207.USD","LU0056508442.USD","LU2458330169.SGD","LU1551013342.USD","IE00BKDWB100.SGD","AMD","LU0708995583.HKD","SGXZ51526630.SGD","LU0889565916.HKD","LU0308772762.SGD","LU2430703095.HKD","LU0353189680.USD","LU0823426308.USD","LU0315179316.USD","LU2491049909.HKD","BK4559","IE0034235295.USD","LU0871576103.HKD","IE00BD4GTT62.SGD","LU0130518102.USD","LU2089985449.USD","SG9999015341.SGD","LU2108987350.USD","LU0231483743.USD","BK4209","LU2250418816.HKD","LU0072462426.USD","LU0082616367.USD","LU2092627202.USD","GB00BDT5M118.USD","SGXZ81514606.USD","LU1674673428.USD","LU1242518931.SGD","LU0516422952.EUR","LU1868837136.USD","IE00BMPRXN33.USD","LU0096364046.USD","LU1815333072.USD","LU0342679015.USD","LU2097344357.USD","LU0345768740.USD","LU1770034418.SGD","LU1935042488.USD","LU0466842654.USD","LU2756315664.SGD","LU1914381329.SGD","LU0267386448.USD","LU0965509101.SGD","LU2462157665.USD","BK4527","SG9999015952.SGD","LU0957808578.USD","LU1861220033.SGD","IE00BQXX3D17.EUR","LU0456827905.SGD","LU0823426480.USD","LU0081259029.USD","IE00BQXX3F31.USD","LU0061474960.USD","LU1951198990.SGD","LU0234572021.USD","LU0964807845.USD","LU0323591593.USD","LU0215105999.USD","LU0345769128.USD","BK4220","IE00BQXX3C00.GBP","LU1116320737.USD","LU0648000940.SGD","3NVD.UK","LU0788109477.HKD","BK4543","LU0633140727.USD","LU2098885051.SGD","LU2399975544.HKD","LU0823413660.USD","LU1974910355.USD","LU0605514214.HKD","HK0000320264.USD","LU2237438978.USD","LU0943347566.SGD","LU2360032135.SGD","IE00BDCRKT87.USD","LU2294711713.HKD","SG9999002224.SGD","LU0502904849.HKD","LU0289961442.SGD","LU1037948541.HKD","LU2237957902.USD","LU1066051498.USD","LU0109392836.USD","LU2471134523.USD","BK4526","PDD","LU1069344957.HKD","LU0820561909.HKD","LU1496350502.SGD","LU2125154778.USD","LU2463028550.USD","LU2505996681.GBP","BK4512","LU0370786039.SGD","SG9999004303.SGD","IE00B0JY6N72.USD","IE0004445015.USD","NVDL","LU2168564149.EUR","DASH","BK4509","LU1548497426.USD","LU1066051811.HKD","LU0823397103.USD","IE00BJTD4N35.SGD","LU0348827113.USD","LU0823434583.USD","BK4592","SG9999001424.SGD","LU0516423174.USD","LU1791710400.SGD","IE00BWXC8680.SGD","HK0000320223.HKD","LU1119994496.HKD","BK4549","LU0354030511.USD","LU0006306889.USD","LU0061475181.USD","LU0170899867.USD","NVDU","LU0561508036.HKD","NVDS","LU2420271590.USD","BK4139","LU0097036916.USD","BK4548","LU0348723411.USD","LU0823421416.USD","BK4608","CHTR","BK4532","LU0531971595.HKD","LU1023057109.AUD","SG9999000418.SGD","TTD","BK4587","IE00B7KXQ091.USD","LU0047713382.USD","LU1868838027.USD","LU2083900584.USD","LU1808992512.USD","LU1093756325.SGD","LU1232071149.USD","LU2168564065.EUR","LU0238689110.USD","LU0572944931.SGD","LU0039217434.USD","LU0329678337.USD","LU0476273544.USD","LU2065171311.SGD","LU1303367103.USD","LU2290526834.HKD","NVD2.UK","LU0266013472.USD","LU2471134796.USD","LU1868837722.USD","IE00BZ199S13.USD","LU1815336760.USD","LU1804176565.USD","LU0079474960.USD","LU2433249047.HKD","LU0310800379.SGD","SG9999015358.SGD","LU0114720955.EUR","LU0594300179.USD","IE00BD4GTW91.USD","LU0640476718.USD","LU2491050071.SGD","NVDX","LU1814569148.SGD","LU0251132253.USD","LU0823416689.USD","LU1366192091.USD","LU1989772840.SGD","LU2023250504.SGD","BK4528","LU1633808545.USD","LU0861579265.USD","LU2326559502.SGD","LU0494093205.USD","LU2552382132.HKD","LU0061474705.USD","SG9999002232.USD","LU0516422440.USD","LU0320765992.SGD","LU2360107168.USD","SG9999014542.SGD","LU2264538146.SGD","LU0878005551.USD","LU2286300806.USD","LU0390134368.USD","LU2430703251.USD","LU2023250330.USD","IE00BMPRXQ63.HKD","BK4529","LU0348825331.USD","LU1629891620.HKD","LU1935043023.USD","LU2403377893.USD","LU1323610961.USD","LU1201861165.SGD","BK4505","LU0130103400.USD","BK4585","LU2362541513.USD","SGXZ99366536.SGD","LU0053666078.USD","LU2357125470.USD","LU0882574139.USD","IE0004445239.USD","LU0348788117.USD","IE00BSNM7G36.USD","BK4009","LU2125909916.SGD","LU1084165304.USD","LU2211815571.USD","LU2039709279.SGD","LU0787776722.HKD","LU0256863902.USD","LU0109394709.USD","LU0320765489.SGD","LU1880383440.USD","LU0708994859.HKD","LU0689472784.USD","LU1961090484.USD","LU1794554557.SGD","LU2092937148.SGD","IE00BJLML261.HKD","LU0058720904.USD","LU0353189763.USD","SG9999015986.USD","LU0208291251.USD","LU2361044865.SGD","LU2087621335.USD","LU0048584097.USD","LU2413666426.HKD","LU0823414478.USD","LU0256863811.USD","BK4614","IE00BMPRXR70.SGD","LU0070302665.USD","LU0979878070.USD","LU2324357040.USD","LU1956131251.USD","NVDD","LU0417516902.SGD","LU1861215975.USD","LU1064131342.USD","LU0345770308.USD","LU2125154935.USD","LU2506951792.HKD","LU2168563687.JPY","LU1989764664.SGD"],"gpt_icon":0},{"id":"2551193797","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193797","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551193797?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:01","pubTimestamp":1752591665,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-15Nasdaq 100 .NDXTop PerformersPercent ChangeTrade Desk Inc TTD.OQ+8.6%Advanced Micro Devices Inc AMD.OQ+6.5%NVIDIA Corp NVDA.OQ+4.2%Synopsys Inc SNPS.OQ+2.3%PDD Holdings Inc PDD.OQ+2.0%Bottom PerformersPercent ChangeDoorDash Inc DASH.OQ-2.9%Regeneron Pharmaceuticals Inc REGN.OQ-2.5%Gilead Sciences Inc GILD.OQ-2.5%Constellation Energy Corp CEG.OQ-2.4%Charter Communications Inc CHTR.OQ-2.2%The Nasdaq 100 .NDX gained 75.29 points, or 0.33%, to 22,930.92 and recorded 5 new highs and one new low. 33 stocks rose and 68 fell as declining issues outnumbered advancers by about a 2.1-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"BUZZ-2025-07-15美国东部时间上午11:01左右纳斯达克表现最高和最低的股票","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nL8N3TC1EP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","LU2125154778.USD","NVDD","SNPS","LU0823414478.USD","NVIW.SI","REGN","LU1242518931.SGD","LU2083900584.USD","LU1323610961.USD","NVDX","TTD","LU2326559502.SGD","LU0225283273.USD","LU0516422366.SGD","NVD2.UK","HK0000320223.HKD","LU0289739699.SGD","SG9999014674.SGD","SGXZ99366536.SGD","LU2065171311.SGD","LU0320764599.SGD","NVDU","LU0342679015.USD","BK4598","NVD","LU1961090484.USD","NVDY","LU1633808545.USD","LU0052750758.USD","GILD","LU0820561909.HKD","NVDS.UK","LU2463028550.USD","2NVD.UK","LU0594300419.USD","AMD","NVDA","LU0516422440.USD","NVD3.UK","CEG","3NVD.UK","NVDS","LU1280957306.USD","SNVD.UK","LU2756315318.SGD","DASH","CHTR"],"gpt_icon":1},{"id":"2551196978","title":"再生元制药公司7月14日成交额为4.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551196978?lang=zh_cn&edition=full","pubTime":"2025-07-15 13:25","pubTimestamp":1752557141,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，再生元制药公司成交额为4.09亿美元，成交额较昨日减少14.27%，当日成交量为71.71万股。再生元制药公司于2025年7月14日涨0.5%，报570.59美元，该股过去5个交易日涨6.04%，年初至今跌19.67%，过去60日涨2.43%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715132549a6aa4bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU2106854487.HKD","LU0823416689.USD","LU2362540622.SGD","LU2023250504.SGD","BK4588","LU2468319806.SGD","LU0882574055.USD","LU0823434740.USD","LU0109394709.USD","LU0320765992.SGD","LU0823434583.USD","LU0058720904.USD","LU1917777945.USD","REGN","LU1974910355.USD","LU2362541273.HKD","LU2237438978.USD","LU0289739699.SGD","LU0889565916.HKD","LU2089984988.USD","LU0114720955.EUR","BK4585","LU2362541513.USD","LU0053666078.USD"],"gpt_icon":0},{"id":"2550992664","title":"Accelerated FDA Approval of Lynozyfic May Change the Case for Investing in Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550992664","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550992664?lang=zh_cn&edition=full","pubTime":"2025-07-12 14:02","pubTimestamp":1752300139,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals recently received accelerated FDA approval for Lynozyfic (linvoseltamab-gcpt) to treat adults with relapsed or refractory multiple myeloma who have undergone at least four prior therapies, addressing a significant medical need in oncology.\nThis regulatory milestone not only bolsters Regeneron's late-stage cancer portfolio but also overcomes earlier manufacturing challenges that delayed approval, enhancing the company's outlook in a competitive...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"FDA加速批准Lynozyfic可能会改变投资再生元(REGN)的理由","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/accelerated-fda-approval-of-lynozyfic-may-change-the-case-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0882574055.USD","LU2362540622.SGD","LU0320765992.SGD","LU2237438978.USD","LU0058720904.USD","LU2362541273.HKD","LU2023250504.SGD","BK4139","LU0114720955.EUR","LU0823416689.USD","REGN","LU0053666078.USD","BK4585","LU0823434740.USD","LU1917777945.USD","LU2106854487.HKD","LU0289739699.SGD","LU1974910355.USD","LU0823434583.USD","LU0109394709.USD","BK4588","LU2362541513.USD","LU2089984988.USD","LU0889565916.HKD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2550312999","title":"再生元制药公司7月11日成交额为4.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550312999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550312999?lang=zh_cn&edition=full","pubTime":"2025-07-12 13:14","pubTimestamp":1752297289,"startTime":"0","endTime":"0","summary":"美东时间2025年7月11日，再生元制药公司成交额为4.77亿美元，成交额较昨日增加2.92%，当日成交量为84.46万股。再生元制药公司于2025年7月11日涨1.43%，报567.74美元，该股过去5个交易日涨3.72%，年初至今跌20.07%，过去60日跌0.43%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712131456a4460f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823416689.USD","LU0823434740.USD","LU2468319806.SGD","BK4139","LU0058720904.USD","REGN","LU2237438978.USD","LU0053666078.USD","LU0109394709.USD","LU2362541273.HKD","LU1917777945.USD","LU2362540622.SGD","LU0114720955.EUR","LU0823434583.USD","LU0882574055.USD","LU2089984988.USD","LU2106854487.HKD","LU0889565916.HKD","BK4588","LU0289739699.SGD","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"2550966633","title":"Regeneron Pharma Is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966633?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:09","pubTimestamp":1752260940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 11, 2025 15:09 ET (19:09 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"瑞银维持再生元制药的评级为中性","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2550968645","title":"Regeneron Pharmaceuticals Launches Long-Term Follow-Up Study on Gene Modified T Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2550968645","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550968645?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:27","pubTimestamp":1752251233,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is initiating a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regeneron-pharmaceuticals-launches-long-term-follow-up-study-on-gene-modified-t-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"再生元制药启动基因修饰T细胞疗法长期随访研究","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regeneron-pharmaceuticals-launches-long-term-follow-up-study-on-gene-modified-t-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","LU1917777945.USD","REGN","LU0114720955.EUR","LU0320765992.SGD","LU0889565916.HKD","LU0882574055.USD","LU2023250504.SGD","LU0823434740.USD","LU2362540622.SGD","BK4585","LU1974910355.USD","LU2089984988.USD","LU2468319806.SGD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","LU0289739699.SGD","BK4139","LU2362541513.USD","LU2237438978.USD","BK4588","LU0823416689.USD","LU0109394709.USD","LU0823434583.USD"],"gpt_icon":0},{"id":"2550954563","title":"UBS Raises Price Target on Regeneron Pharmaceuticals to $584 From $560, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550954563","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550954563?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:21","pubTimestamp":1752243712,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $726.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"瑞银将再生元制药目标价从560美元上调至584美元，维持中性评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"gpt_icon":0},{"id":"2550799266","title":"US judge won't block 23andMe bankruptcy sale to co-founder","url":"https://stock-news.laohu8.com/highlight/detail?id=2550799266","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550799266?lang=zh_cn&edition=full","pubTime":"2025-07-11 05:22","pubTimestamp":1752182553,"startTime":"0","endTime":"0","summary":"US judge won't block 23andMe bankruptcy sale to co-founderBy Daniel Wiessner. July 10  - A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne Wojcicki pending the outcome of a legal challenge by California.U.S. District Judge Matthew Schelp in St. Louis, Missouri, during a hearing said he would not pause the $305 million sale while he reviews the state's bid for a declaration that 23andMe cannot sell California customers' genetic data without their consent.    A bankruptcy judge rejected those claims on Monday, and California had appealed that ruling to Schelp, who on Tuesday had briefly paused the sale ahead of Thursday's hearing. 23andMe, which filed for bankruptcy in March, is selling its assets to TTAM Research, a new nonprofit founded by Wojcicki.On Thursday, Bernard Eskandari of the California Attorney General's office told Schelp that the state would have investigated and brought an enforcement action against","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"美国法官不会阻止23andMe破产出售给联合创始人","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nL1N3T40LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU2106854487.HKD","LU0823434583.USD","LU0882574055.USD","LU0058720904.USD","LU0889565916.HKD","LU0053666078.USD","LU0289739699.SGD","LU1974910355.USD","LU2237438978.USD","MEHCQ","LU0320765992.SGD","BK4139","LU0823434740.USD","LU0823416689.USD","BK4588","LU2362541513.USD","BK4585","LU2089984988.USD","LU0109394709.USD","BK4196","LU0114720955.EUR","REGN","LU2023250504.SGD","LU2362540622.SGD","LU1917777945.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2550414676","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2550414676","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550414676?lang=zh_cn&edition=full","pubTime":"2025-07-11 04:46","pubTimestamp":1752180360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rallied 1.30% to $559.76 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.27% to 6,280.46 and the Dow Jones Industrial Average  rising 0.43% to 44,650.64.This was the stock's third consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 53.78% below its 52-week high of $1,211.20, which the company achieved on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc.  rose 1.30% to $300.37, Moderna Inc.  rose 4.54% to $34.28, and Gilead Sciences Inc.  rose 1.15% to $114.54.Trading volume  remained 563,143 below its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is pu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"再生元制药公司股票在强劲交易日表现优于竞争对手","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2550462785","title":"Regeneron Pharma Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2550462785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550462785?lang=zh_cn&edition=full","pubTime":"2025-07-11 00:23","pubTimestamp":1752164580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 10, 2025 12:23 ET (16:23 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"Regeneron Pharma由Morgan Stanley维持在跑赢大盘","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2550629919","title":"Refile- Regeneron Pharmaceuticals Inc. : Morgan Stanley Cuts Target Price to $754.00 From $755.00 (Fixes Company Name)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550629919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550629919?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:26","pubTimestamp":1752157577,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Refile-再生元制药公司：大摩将目标价从755.00美元下调至754.00美元（修正公司名称）","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nL4N3T717T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2106854487.HKD","LU0889565916.HKD","LU0114720955.EUR","LU2023250504.SGD","LU2362541513.USD","LU0320765992.SGD","REGN","LU0053666078.USD","LU2237438978.USD","LU2362541273.HKD","LU1974910355.USD","LU0882574055.USD","LU0823434740.USD","LU2468319806.SGD","LU0289739699.SGD","LU0823434583.USD","BK4585","BK4588","BK4139","LU2362540622.SGD","LU0823416689.USD","LU0058720904.USD","LU0109394709.USD","LU1917777945.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2550623778","title":"Morgan Stanley Adjusts Price Target on Regeneron Pharmaceuticals to $754 From $755, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550623778","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550623778?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:21","pubTimestamp":1752153661,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $726.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"大摩将再生元制药目标价从755美元调整至754美元，维持跑赢大盘评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"gpt_icon":0},{"id":"2550628211","title":"Inc. : Morgan Stanley  Cuts Target Price to $754.00 From $755.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2550628211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550628211?lang=zh_cn&edition=full","pubTime":"2025-07-10 20:52","pubTimestamp":1752151943,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Inc.：摩根士丹利将目标价从755.00美元下调至754.00美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nAZN45EBY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0882574055.USD","LU0058720904.USD","LU0053666078.USD","REGN","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","LU0823434583.USD","BK4588","BK4139","BK4585","LU2106854487.HKD","LU2362540622.SGD","LU0823416689.USD","LU1917777945.USD","LU2362541513.USD","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU2023250504.SGD","LU2237438978.USD","LU0823434740.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2550692989","title":"再生元制药公司7月9日成交额为4.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550692989","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550692989?lang=zh_cn&edition=full","pubTime":"2025-07-10 13:22","pubTimestamp":1752124949,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，再生元制药公司成交额为4.65亿美元，成交额较昨日减少0.25%，当日成交量为84.39万股。再生元制药公司于2025年7月9日涨0.88%，报552.58美元，该股过去5个交易日涨3.3%，年初至今跌22.21%，过去60日涨1.28%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710132235a6a0d2b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362541273.HKD","LU0823434583.USD","LU0114720955.EUR","LU2023250504.SGD","LU0289739699.SGD","BK4585","LU1974910355.USD","LU2106854487.HKD","LU0320765992.SGD","LU2468319806.SGD","LU0109394709.USD","LU1917777945.USD","REGN","LU2237438978.USD","LU2362540622.SGD","LU0882574055.USD","LU0889565916.HKD","LU2362541513.USD","LU0053666078.USD","BK4139","LU0058720904.USD","LU0823434740.USD","BK4588","LU0823416689.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2550317658","title":"Maia Biotechnology Inc. Expands Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer with First Patient Dosed in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2550317658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550317658?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:15","pubTimestamp":1752066924,"startTime":"0","endTime":"0","summary":"Maia Biotechnology Inc. Expands Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer with First Patient Dosed in Taiwan. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on July 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Maia Biotechnology Inc.扩大Ateganosine治疗晚期非小细胞肺癌的2期试验，台湾首例患者接受给药","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL5SDGD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","LU2023250504.SGD","LU0289739699.SGD","LU0889565916.HKD","LU0109394709.USD","BK4585","LU1917777945.USD","LU2362541513.USD","LU2362541273.HKD","LU2089984988.USD","LU0823416689.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","LU2106854487.HKD","REGN","LU0114720955.EUR","LU0882574055.USD","LU0320765992.SGD","LU0058720904.USD","LU2237438978.USD","LU0823434583.USD","BK4588","LU1974910355.USD","MAIA","LU0053666078.USD"],"gpt_icon":0},{"id":"2550507822","title":"再生元制药公司7月8日成交额为4.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550507822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550507822?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:22","pubTimestamp":1752038547,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，再生元制药公司成交额为4.66亿美元，成交额较昨日减少9.67%，当日成交量为84.74万股。再生元制药公司于2025年7月8日涨1.79%，报547.75美元，该股过去5个交易日涨4.33%，年初至今跌22.89%，过去60日跌4.88%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709132236a43f8676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362540622.SGD","LU2362541273.HKD","BK4588","LU1917777945.USD","BK4585","LU0320765992.SGD","LU2023250504.SGD","LU0823434740.USD","LU2468319806.SGD","LU0058720904.USD","BK4139","LU2362541513.USD","LU0823434583.USD","LU0114720955.EUR","LU0882574055.USD","LU0889565916.HKD","LU2089984988.USD","LU2237438978.USD","LU0053666078.USD","LU2106854487.HKD","LU0289739699.SGD","LU1974910355.USD","REGN","LU0823416689.USD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":0.0604},{"period":"1month","weight":0.0781},{"period":"3month","weight":0.0227},{"period":"6month","weight":-0.1888},{"period":"1year","weight":-0.4813},{"period":"ytd","weight":-0.199}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"再生元制药公司于1988年在纽约州成立。再生元制药公司是一家完全集成的生物技术公司，它发现、发明、开发、制造和商业化治疗严重疾病的药物。其正在开发的商业化药物和候选产品旨在帮助患有眼疾、过敏性和炎症性疾病、癌症、心血管和代谢性疾病、疼痛、传染病和罕见疾病的患者。它的核心业务战略是在基础科学研究和发现启用技术方面保持坚实的基础，并建立在临床开发、制造和商业能力的基础上。其目标是继续成为一家综合性、多产品的生物技术公司，为患者和医疗专业人员提供预防和治疗人类疾病的重要选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.529412,"avgChangeRate":0.03899},{"month":2,"riseRate":0.411765,"avgChangeRate":0.087815},{"month":3,"riseRate":0.470588,"avgChangeRate":-0.044318},{"month":4,"riseRate":0.470588,"avgChangeRate":0.017191},{"month":5,"riseRate":0.628571,"avgChangeRate":0.057479},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006745},{"month":7,"riseRate":0.657143,"avgChangeRate":0.054013},{"month":8,"riseRate":0.529412,"avgChangeRate":0.02165},{"month":9,"riseRate":0.470588,"avgChangeRate":0.0249},{"month":10,"riseRate":0.382353,"avgChangeRate":-0.006135},{"month":11,"riseRate":0.529412,"avgChangeRate":0.041578},{"month":12,"riseRate":0.5,"avgChangeRate":0.045405}],"exchange":"NASDAQ","name":"再生元制药公司","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再生元制药公司(REGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再生元制药公司,REGN,再生元制药公司股票,再生元制药公司股票老虎,再生元制药公司股票老虎国际,再生元制药公司行情,再生元制药公司股票行情,再生元制药公司股价,再生元制药公司股市,再生元制药公司股票价格,再生元制药公司股票交易,再生元制药公司股票购买,再生元制药公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再生元制药公司(REGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}